Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats

Objective: To investigate the antifibrotic effects of Chrysanthemum indicum ethanol extract (CIEE) against activated hepatic stellate cells (HSC) and thioacetamide (TAA)-induced hepatofibrosis in rats. Methods: Cell viability and proliferation of HSC-T6 cells were measured using MTT assay. Primary H...

Full description

Bibliographic Details
Main Authors: Yun-Jin Chae, Sushruta Koppula, Myong-Ki Kim, Tony Yoon, MinDong Song
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Asian Pacific Journal of Tropical Biomedicine
Subjects:
Online Access:http://www.apjtb.org/article.asp?issn=2221-1691;year=2021;volume=11;issue=11;spage=500;epage=509;aulast=Chae
_version_ 1798037478692618240
author Yun-Jin Chae
Sushruta Koppula
Myong-Ki Kim
Tony Yoon
MinDong Song
author_facet Yun-Jin Chae
Sushruta Koppula
Myong-Ki Kim
Tony Yoon
MinDong Song
author_sort Yun-Jin Chae
collection DOAJ
description Objective: To investigate the antifibrotic effects of Chrysanthemum indicum ethanol extract (CIEE) against activated hepatic stellate cells (HSC) and thioacetamide (TAA)-induced hepatofibrosis in rats. Methods: Cell viability and proliferation of HSC-T6 cells were measured using MTT assay. Primary HSCs were used to study morphology. TAA (200 mg/kg) was used to induced hepatic fibrosis in rats. CIEE (100 and 500 mg/kg) and silymarin (50 mg/kg) were administered orally. Liver functions including alanine transaminase, aspartate transaminase, glutathione, and hydroxyproline levels were measured using commercial kits. Liver sections and fibrotic biomarker expression were measured using hematoxylin and eosin staining and real-time polymerase chain reaction. Results: In vitro study revealed that CIEE (0.1, 0.25, and 0.5 mg/mL) inhibited the proliferation of activated HSCs exposed to transforming growth factor (TGF)-β and restored the activated primary HSC morphology. In in vivo studies, TAA-induced increase in liver/body weight ratio (5.46 ± 0.26) was significantly reduced (4.13 ± 0.22) by CIEE (P<0.05 at 500 mg/kg). CIEE (100 and 500 mg/kg) improved the liver functions by significantly attenuating changes in alanine transaminase, aspartate transaminase, glutathione, and hydroxyproline levels (P<0.05). Further, CIEE (100 and 500 mg/kg) ameliorated the histological changes in liver tissue and TGF-β expression significantly (P<0.05) in TAA-induced rats. Conclusions: CIEE significantly protects against TAA-induced liver damage in rats and can be used in the treatment of liver fibrosis.
first_indexed 2024-04-11T21:27:05Z
format Article
id doaj.art-be023b7404f04b34a91bbabc88e4f659
institution Directory Open Access Journal
issn 2221-1691
2588-9222
language English
last_indexed 2024-04-11T21:27:05Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Pacific Journal of Tropical Biomedicine
spelling doaj.art-be023b7404f04b34a91bbabc88e4f6592022-12-22T04:02:21ZengWolters Kluwer Medknow PublicationsAsian Pacific Journal of Tropical Biomedicine2221-16912588-92222021-01-01111150050910.4103/2221-1691.328057Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in ratsYun-Jin ChaeSushruta KoppulaMyong-Ki KimTony YoonMinDong SongObjective: To investigate the antifibrotic effects of Chrysanthemum indicum ethanol extract (CIEE) against activated hepatic stellate cells (HSC) and thioacetamide (TAA)-induced hepatofibrosis in rats. Methods: Cell viability and proliferation of HSC-T6 cells were measured using MTT assay. Primary HSCs were used to study morphology. TAA (200 mg/kg) was used to induced hepatic fibrosis in rats. CIEE (100 and 500 mg/kg) and silymarin (50 mg/kg) were administered orally. Liver functions including alanine transaminase, aspartate transaminase, glutathione, and hydroxyproline levels were measured using commercial kits. Liver sections and fibrotic biomarker expression were measured using hematoxylin and eosin staining and real-time polymerase chain reaction. Results: In vitro study revealed that CIEE (0.1, 0.25, and 0.5 mg/mL) inhibited the proliferation of activated HSCs exposed to transforming growth factor (TGF)-β and restored the activated primary HSC morphology. In in vivo studies, TAA-induced increase in liver/body weight ratio (5.46 ± 0.26) was significantly reduced (4.13 ± 0.22) by CIEE (P<0.05 at 500 mg/kg). CIEE (100 and 500 mg/kg) improved the liver functions by significantly attenuating changes in alanine transaminase, aspartate transaminase, glutathione, and hydroxyproline levels (P<0.05). Further, CIEE (100 and 500 mg/kg) ameliorated the histological changes in liver tissue and TGF-β expression significantly (P<0.05) in TAA-induced rats. Conclusions: CIEE significantly protects against TAA-induced liver damage in rats and can be used in the treatment of liver fibrosis.http://www.apjtb.org/article.asp?issn=2221-1691;year=2021;volume=11;issue=11;spage=500;epage=509;aulast=Chaechrysanthemum indicum; fibrosis; hepatoprotective; hydroxyproline; thioacetamide
spellingShingle Yun-Jin Chae
Sushruta Koppula
Myong-Ki Kim
Tony Yoon
MinDong Song
Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
Asian Pacific Journal of Tropical Biomedicine
chrysanthemum indicum; fibrosis; hepatoprotective; hydroxyproline; thioacetamide
title Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
title_full Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
title_fullStr Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
title_full_unstemmed Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
title_short Chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide-induced hepatofibrosis in rats
title_sort chrysanthemum indicum ethanol extract attenuates hepatic stellate cell activation in vitro and thioacetamide induced hepatofibrosis in rats
topic chrysanthemum indicum; fibrosis; hepatoprotective; hydroxyproline; thioacetamide
url http://www.apjtb.org/article.asp?issn=2221-1691;year=2021;volume=11;issue=11;spage=500;epage=509;aulast=Chae
work_keys_str_mv AT yunjinchae chrysanthemumindicumethanolextractattenuateshepaticstellatecellactivationinvitroandthioacetamideinducedhepatofibrosisinrats
AT sushrutakoppula chrysanthemumindicumethanolextractattenuateshepaticstellatecellactivationinvitroandthioacetamideinducedhepatofibrosisinrats
AT myongkikim chrysanthemumindicumethanolextractattenuateshepaticstellatecellactivationinvitroandthioacetamideinducedhepatofibrosisinrats
AT tonyyoon chrysanthemumindicumethanolextractattenuateshepaticstellatecellactivationinvitroandthioacetamideinducedhepatofibrosisinrats
AT mindongsong chrysanthemumindicumethanolextractattenuateshepaticstellatecellactivationinvitroandthioacetamideinducedhepatofibrosisinrats